Practice-Changing Advancements in the First-Line Treatment of Advanced and Metastatic Urothelial Cancer: Optimizing Patient Care - CME

CME

Title: Practice-Changing Advancements in the First-Line Treatment of Advanced and Metastatic Urothelial Cancer: Optimizing Patient Care

Description: This program will prepare clinicians with a comprehensive understanding of the appropriate treatment and management of patients with la/mUC and the clinical utility of agents that could significantly impact patient outcomes. As novel therapeutic regimens continue to enter the first-line setting, clinical decision-making and treatment sequencing will become increasingly complex. This program will educate clinicians on how to stay abreast of the latest clinical trial data and evidence-based guidelines, along with strategies for implementing optimal multidisciplinary care coordination and AE management to successfully integrate novel therapies into practice and drive sustainable patient outcomes.

Target Audience: This activity series is designed to meet the educational needs of Medical Oncologists, Urologists, Oncology Nurses, Pharmacists, NPs/PAs and other health care professionals who treat patients with bladder cancer.

Learning Objectives

Appraise the latest efficacy and safety data from clinical trials supporting the integration of novel IO-based regimens for veterans with la/mUC
Formulate treatment plans aligned with current practice guidelines for veterans with la/mUC, including consideration of eligibility criteria and previously received therapy
Apply a multidisciplinary team approach to developing comprehensive treatment plans based on disease- and patient-specific characteristics for patients with la/mUC within the VA health system
Devise expert and team-based strategies to identify, monitor, and manage AEs associated with novel IO-based regimens, including immune-related AEs

Disclosures and Disclaimers: The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, PleXus Communications, and/or Merck Sharp & Dohme LLC. Authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

Accredited Providers

Commercial Support

Credit Information

Credit Type	Units / Unit Type	Board
AMA PRA Category 1 Credit	1 Credits	ACCME- Accreditation Council for Continuing Medical Education
Nursing	1 Contact Hours	ANCC - American Nurses Credentialing Center
Pharmacy	1 Contact Hours	ACPE- Accreditation Council for Pharmacy Education